baber/WOPTO huggingface dataset:
Patent NZ-206394-A (NZ)
Title: Chromogenic tri- or tetrapeptides and detection and/or determination of enzymes
Inventor: HEBER H
IPC: C07K5/02
Filed: 1983-11-25
Abstract: Chromogenic compounds of the formula I    <IMAGE>  (I)  and a process for their preparation are described, X denoting a hydrogen atom, a protective group customarily used in peptide chemistry or a group which irreversibly blocks the terminal amino group, A and P being identical or different and denoting an alpha-, beta- or gamma-amino acid which is composed of 2 to 15 carbon atoms with up to 3 nitrogen atoms, 2 sulfur atoms and 6 oxygen atoms, the side-chain of which can be substituted, and P also denoting a dipeptide formed from amino acids of these types, B denoting arginine, homoarginine, lysine, homolysine, ornithine or histidine and R denoting a substituent in the 2- or 3-position. The compounds can be used as substrates for the direction and the quantitative determination of hydrolytic enzymes of enzyme class 3.4.21.
Patent NZ-208022-A (NZ)
Title: Ih-imidazole-1-ethanol esters and pharmaceutical compositions
Inventor: HOFMAN P S
IPC: C07D233/60
Filed: 1984-05-02
Abstract: The invention relates to the use of 1-H-imidazol-1-ethanol and compounds of the formula 
<CHEM>
 in which R represents an organic acid residue which does not bear further carboxyl groups, either in the free or salt form, as sebum synthesis inhibitors. 
<??>The invention also relates to parmaceutical preparations comprising a compound of formula I, and their preparation and to the compounds of formula I in which R is as defined above except the acetic acid residue, and their preparation.
Patent NZ-212997-A (NZ)
Title: Elastic strands attached to fabric by sinusoidal adhesive line or lines
Inventor: POMPARELLI V
IPC: A61F13/15
Filed: 1985-08-05
Abstract: An elastic means is provided for a disposable diaper which elastic means has substantially parallel multiple strands of stretched elastic adhered between two layers of fabric by at least one sinusoidal adhesive line.
Patent NZ-215670-A (NZ)
Title: Duplex digital equalising filter
Inventor: BAUER A G
IPC: H04B/
Filed: 1986-04-02
Abstract: PCT No. PCT/SE86/00162 Sec. 371 Date Dec. 12, 1986 Sec. 102(e) Date Dec. 12, 1986 PCT Filed Apr. 8, 1986 PCT Pub. No. WO86/06567 PCT Pub. Date Nov. 6, 1986.In particular, there are provided in accordance with the invention a method and apparatus for adjusting a digital equalizing filter in a hybrid circuit in a telecommunication system for transmitting digital information in duplex on a single line pair with simultaneous adaptive echo elimination and adaptive elimination of noise caused by intersymbol interference, where a first and a second compensation signal (e(t), i(t)), which are respectively dependent on the stored parameters of a digital balance filter and an equalizing filter, are subtracted from a received signal (a(t)+e(t)+i(t)) to form a difference signal (r(t)) which is compensated for noise respectively caused by echoes and intersymbol interference, the balance filter parameters being corrected with the aid of a correction signal ( epsilon B kappa ) dependent on the difference signal (r(t)). The equalizing filter parameters are adjusted with the aid of a further correction signal ( epsilon U kappa ) formed by the balance filter correction signal ( epsilon B kappa ) and the first compensation signal (ê(t)) such that the further correction signal ( epsilon U kappa ) will substantially agree with the balance filtercorrection signal ( epsilon B kappa ), but obtain the value zero when the first compensation signal (ê(t)) and the balance filter correction signal ( epsilon B kappa ) are both positive simultaneously or negative simultaneously. There is thus prevented the correction sequence of the equalizing filter parameters when the balance filter parameters are changed in a direction such that the absolute value of the estimated echo (ê(t)) increases.
Patent NZ-220252-A (NZ)
Title: Cargo bag with integral lifting loops
Inventor: MARINO F J
IPC: B65D33/14
Filed: 1987-05-11
Abstract: Four pairs of lifting panels (30-3l, 32-33, 34-35, 36-37) extend upwardly from and have their lower end portions formed integrally with the upper edges of the side walls (l5-l8) of the cargo bag. Each of the four pairs of lifting panels includes a pair of adjacent lifting panels positioned adjacent a corresponding corner of the cargo bag and the upper end portions of the lifting panels are folded inwardly to form multi-plies thereof (Figure 5). The multi-ply upper end portions of adjacent lifting panels are positioned in overlapping relationship and are interconnected (45) to form a lifting loop (40-43) above each corner of the cargo bag for supporting and moving the cargo bag from one location to another.
Patent NZ-221598-A (NZ)
Title: Handle arrangement for sleeve-type beverage carrier
Inventor: WILSON J F
IPC: B65D/
Filed: 1987-08-27
Abstract: A sleeve-type beverage can carrier having a transversely arranged handle opening in the top panel. The opening is covered by flaps foldably connected to the top panel along the transversely extending elongated edges of the handle opening, each flap being formed of individual tabs which facilitate the folding down of the flap by the fingers of a user. The elongated edges are tapered so that they are the most widely spaced apart midway along their length and the closest together near their ends. This arrangement causes the top panel on both sides of the handle opening to bow upwardly when the carrier is lifted to distribute the lifting stresses through the top panel and the upper portions of the side panels.
Patent NZ-224663-A (NZ)
Title: Fusion proteins containing glutathione-s-transferase and expression of foreign polypeptides using glutathione-s-transferase encoding vectors
Inventor: SMITH DONALD BRUCE
IPC: C07K19/00
Filed: 1988-05-17
Abstract: A recombinant DNA molecule is claimed comprising a nucleotide sequence which codes on expression for a fusion protein in which a foreign protein or peptide is fused with a glutathione-S-trasferase (GST) enzyme. Pref. the enzyme is a 26kD GST of Schistosoma japonicum. The foreign protein or peptide may be fused to the enzyme through a lint cleavable by e.g. thrombin, blood coagulation factor Xa or renin. Also claimed is an expression vector having inserted a nucleotide sequence capable of being expressed as a GST enzyme followed by at least one restriction endonuclease recognition site for insertion of a nucleotide sequence capable of being expressed as a Foreign protein or peptide fused to the GST. The fusion protein is also claimed.
Patent NZ-225079-A (NZ)
Title: Long distance transport of hydrocarbons using gas-poor hydrocarbon liquid carrier
Inventor: HAMMEL B
IPC: F17D1/00
Filed: 1988-06-17
Abstract: PCT No. PCT/NO88/00056 Sec. 371 Date Dec. 7, 1989 Sec. 102(e) Date Dec. 7, 1989 PCT Filed Jun. 22, 1988 PCT Pub. No. WO88/10397 PCT Pub. Date Dec. 29, 1988.A method is disclosed for transport of hydrocarbons in a pipeline flow across large distances, from a first location at an offshore hydrocarbon reservoir to a second location. At said first location a liquid absorbent is provided in the form of a gas-poor hydrocarbon liquid flow. A flow of gas saturated hydrocarbon liquid and released associated hydrocarbon gas is supplied to the gas-poor liquid flow at first location, the volume of gas-poor hydrocarbon liquid being selected so as to be sufficient for all released associated hydrocarbon gas to be absorbed by the gas-poor hydrocarbon liquid. Then the hydrocarbon liquid with absorbed hydrocarbon gas is transported to said second location. A plant for transport of hydrocarbons in a pipeline flow is also disclosed. The plant comprises an absorption chamber (6) at a first location. Absorption chamber (6) is connected to a well pipe (3). At a second location a separator plant (9) is provided. A first pipeline extends from the liquid portion of separator plant (9) to absorption chamber (6). A second pipeline (7) connects absorption chamber (6) with separator plant (9). In said first pipeline (10) the flowing medium can be pressurized by the aid of a high pressure pump (11).
Patent NZ-225604-A (NZ)
Title: Method of solidifying and chemically fixing liquid waste using biogenetic silica
Inventor: CONNER JESSE ROY
IPC: C02F11/14
Filed: 1988-07-28
Abstract: Disclosed is the solidification and chemical fixation of liquid wastes using biogenetic primarily amorphous silica to the waste in the presence of a strong alkali in the waste which converts the biogenetic silica into a soluble silicate, and in the presence of a polyvalent metal ion in the waste which reacts with the soluble silicate to provide a cementitious product of the waste. In the event there is insufficient strong alkali present in the waste to convert the biogenetic amorphous silica to a soluble silicate, and insufficient polyvalent metal ion in the waste to harden and form a cementitious product, amounts of these components as necessary can be added along with the biogenetic silica to the waste. The resulting cementitious and chemically fixed waste can be left in place, for example to provide a land farm, or can be removed and broken up and used as a cover for land fills, various land applications, and farms, as well as other applications.
Patent NZ-231485-A (NZ)
Title: Amino-diol derivatives, preparation and use in pharmaceutical compositions thereof
Inventor: HENNING RAINER
IPC: C07D233/64
Filed: 1989-11-22
Abstract: The invention relates to compounds of the formula I <IMAGE>  in which A is a radical of the formula II <IMAGE> in which E is a CH2 group or a radical NR<9>, G is a radical from the group comprising S, SO, SO2, O, CO, CS or a direct bond, B is an amino acid, D is a heterocycle, and R<1>, R<2>, R<3>, R<4>, R<5>, R<6> and R<9> are defined in the description, and the salts thereof. The invention also relates to a process for preparing the compounds of the formula I and to the use thereof as medicines.
Patent NZ-233657-A (NZ)
Title: 9alpha-hydroxy-3-oxo-4,24(25)-stigmastadien-26-0ic acid derivatives; preparatory processes and pharmaceutical compositions
Inventor: AMBRUS GABOR
IPC: A61K31/565
Filed: 1990-05-11
Abstract: PCT No. PCT/HU90/00033 Sec. 371 Date Feb. 17, 1991 Sec. 102(e) Date Feb. 17, 1991 PCT Filed May 10, 1990 PCT Pub. No. WO90/13559 PCT Pub. Date Nov. 15, 1990.The invention relates to novel 9 alpha -hydroxy-3-oxo-4,24(25)-stigmastadien-26-oic acid derivatives of the formula (I),   <IMAGE> (I)  wherein M stands for hydrogen, C1-4 alkyl or a pharmaceutically accteptable cation to a process for repairing these compounds and to compositions containing said compounds which exert an anti-hypercholesteremic effect.
Patent NZ-234754-A (NZ)
Title: Catalytic hydrogenation of organic feedstock using two reactors connected in parallel
Inventor: HILES ANDREW GEORGES
IPC: C07C29/20
Filed: 1990-08-02
Abstract: PCT No. PCT/GB90/01167 Sec. 371 Date Feb. 12, 1992 Sec. 102(e) Date Feb. 12, 1992 PCT Filed Jul. 27, 1990 PCT Pub. No. WO91/01961 PCT Pub. Date Feb. 21, 1991.In a hydrogenation process, an organic feedstock, such as an unsaturated organic compound containing at least one unsaturated linkage selected from >C=C<, >C=O, -C 3BOND C-, and -C 3BOND N, is contacted with hydrogen in a hydrogenation zone under vapor phase hydrogenation conditions in the presence of a heterogeneous hydrogenation catalyst characterized in that the hydrogenation zone includes first and second hydrogenation reactors connected in parallel, each containing a respective charge of the hydrogenation catalyst, that in a first phase of operations a vaporous mixture containing the organic feedstock and hydrogen is supplied to the first hydrogenation reactor only, that in a second phase of operation subsequent to the first phase the vaporous mixture is supplied to the second hydrogenation reactor only, and that in a third phase of operation subsequent to the second phase the vaporous mixture is supplied simultaneously both to the first hydrogenation reactor and to the second hydrogenation reactor.
Patent NZ-245080-A (NZ)
Title: Double chamber blood container; valves seal each chamber during separation of chambers
Inventor: HOLM NIELS ERIK
IPC: B01D21/26
Filed: 1992-11-10
Abstract: PCT No. PCT/DK92/00329 Sec. 371 Date May 2, 1994 Sec. 102(e) Date May 2, 1994 PCT Filed Nov. 10, 1992 PCT Pub. No. WO93/09753 PCT Pub. Date May 27, 1993.A container for receiving and separating blood plasma into its ingredients comprises two sealingly coupled sections (1 and 2). One container section (2) and the adjacent portion of the other container section are made of solid material, and the two container sections are screwed together. The container sections (1 and 2) comprise their respective chambers (29 and 30) for receiving their respective fluid ingredients, and these chambers are interconnected through a connecting channel (31) through the abutting portions, at which the container sections (1 and 2) are screwed together. A valve seat (21, 27) is shaped at each end of the connecting channel (31) for each valve member (22, 16) for a sealing closing of the chambers (29, 30) in the separated state of the container sections (1, 2). The valve members (22, 16) comprise mutually abutting projections (23, 12) ensuring a distance between the valve members (22, 16) exceeding the distance between the associated valve seats (27, 21) in the coupled state of the container sections (1, 2), but being smaller than the distance between the associated valve seats (27, 21) in a position during a separating movement of the container sections (1, 2). Furthermore, retaining means (15, 16) are provided for ensuring that the valve members (22, 19) do not engage the valve seats (27, 21) in the coupled state of the container sections (1, 2).
Patent NZ-245919-A (NZ)
Title: Cross-connect for sonet signals: selected overhead transmitted as payload
Inventor: NOSER FRANCIS GERARD
IPC: H04J3/16
Filed: 1993-02-17
Abstract: In a SONET cross connect, the same physical link is used between the interfaces and the matrix to carry the overhead and the payload. The cross connection function within the matrix may be used to group, concentrate and route the overhead signals between a server and the matrix. The matrix may also be used to transport signals between servers. Overhead may be grouped and transported as payload. <IMAGE>   <IMAGE> <IMAGE>
Patent NZ-251285-A (NZ)
Title: Field effect transistor controller for direct current motor
Inventor: LANKIN ROBERT
IPC: H02P7/29
Filed: 1993-03-30
Abstract: A MOSFET control topology and a physical structure for a motor control which provide a more efficient and economic DC motor control are disclosed. The control topology introduces a synchronous-rectification technique wherein free-wheel diodes are replaced with MOSFET devices that are switched on and off by a logic circuit so that they are conductive for commuting motor current during periods that the motor current supply is switched off. The physical structure and method of assembling a DC motor control eliminate time consuming assembly techniques while ensuring effective waste heat exchange between electronic components and a heat sink of the control by providing quick-install spring retainers for urging the components into heat sink conducting contact with the heat sink. The physical structure also provides for high density packing of electronic components in a controller.
Patent NZ-253252-A (NZ)
Title: 2,5-dioxo-2,5-dihydro-1h-benz[b]azepines and medicaments
Inventor: CHAPDELAINE MARC JEROME
IPC: A61P25/00
Filed: 1993-06-09
Abstract: Benz[b]azepine compounds, pharmaceutical compositions containing them and methods for the treatment of neurological disorders utilizing them.
Patent NZ-253873-A (NZ)
Title: Recombinant production of "protein disulphide isomerase" (pdi), production of disulphide-bonded recombinant proteins, yeast strains producing pdi
Inventor: TUITE MICHAEL F
IPC: C12N9/90
Filed: 1993-06-02
Abstract: Disclosed is a process for increasing the yield of disulfide bonded recombinant proteins produced by yeast, especially recombinant secreted proteins The enzyme protein disulfide isomerase (PDI) catalyzes the formation of disulfide bonds in secretory and cell-surface proteins. We disclose the construction of recombinant strains of the yeast Saccharomyces cerevisiae which overproduce either human PDI or yeast PDI in a regulated fashion. These strains show greatly increased secretion of disulfide bonded proteins of potential therapeutic significance. These strains have the potential to increase the production of various disulfide bonded proteins.
Patent NZ-257244-A (NZ)
Title: Osmotic dosage form comprising tandospirone or its analogues
Inventor: AYER ATUL D
IPC: A61K9/52
Filed: 1993-10-08
Abstract: A dosage form is provided for administering a drug of the formula   <IMAGE>   to a patient to produce an anxiolytic benefit in the patient.
Patent NZ-264668-A (NZ)
Title: Low calorie fruit spread containing a mixture of carboxymethylcellulose, guar gum and locust bean gum
Inventor: ANTENUCCI ROBERT N
IPC: A23L21/10
Filed: 1994-10-12
Abstract: A reduced calorie fruit spread comprising the gelled product of:     a. water;   b: fruit or fruit flavoring; c. one or more high intensity sweeteners selected from the group consisting of aspartame; saccharin; acesulfame-K; mixtures thereof; and mixtures of aspartame, saccharin, or acesulfame-K with sucralose;     d. low methoxy pectin or carrageenan;   e. carboxymethylcellulose;   f. guar gum; and g. locust bean gum. in
Patent NZ-293585-A (NZ)
Title: Needleless pneumatic injection of active substances to plants
Inventor: HOFFMANN HANS-RAINER
IPC: A01G7/06
Filed: 1995-09-09
Abstract: Needleless pneumatically actuated injection apparatus can be used to inject active substances into plants.
Patent NZ-298638-A (NZ)
Title: Steam superheater device: single heating element produces steam and superheated steam
Inventor: ANNECHARICO ROBERT L
IPC: F22G7/00
Filed: 1995-11-20
Abstract: The present invention relates to a heating device for submersion within a tank of water to boil the water to produce steam, and for superheating the steam, comprising an outer sleeve; an inner sleeve partially disposed through the outer sleeve and having a proximal end, and a distal end in the form of an outlet port, the inner sleeve further defining a vapor chamber; a heating element disposed within the vapor chamber and in electrical communication with an external electrical power supply, the heating element adapted to produce heat in response to electrical energy from the power supply; a steam inlet tube extending outwardly from the inner tube and in fluid communication with the vapor chamber; and a one way valve disposed within the vapor chamber adjacent the outlet port, the valve adapted to selectively gate the flow of vapor from within the vapor chamber through the outlet port; wherein the heating device is configured to heat the water within the tank to a boil to produce steam, the steam inlet tube adapted to direct the steam into the vapor chamber wherein the steam is superheated through direct contact with the heating element producing vapor, the vapor generating sufficient pressure to open the valve and exit the heating device through the outlet port.
Patent NZ-305091-A (NZ)
Title: Vascular endothelial growth factor beta (vegf-b) and its diagnostic and therapeutic use
Inventor: ERIKSSON ULF
IPC: A61K38/00
Filed: 1996-03-01
Abstract: VEGF-B polypeptides from the PDGF family of growth factors having the property of promoting mitosis and proliferation of vascular endothelial cells, DNA sequences encoding these polypeptides, pharmaceutical compositions containing them and antibodies which react with them. The VEGF-B polypeptides are useful in stimulating angiogenesis as well as in diagnostic applications.
Patent NZ-329807-A (NZ)
Title: NK-1 receptor antagonists and P receptor antagonists 2-Diarylmethyl-3-amino-1-azabicyclo[2.2.2]octane derivatives and amino substituted N-containing rings as agents for treating irritable bowel syndrome
Inventor: WILLIAMS STEPHEN ALARIC
IPC: A61K31/445
Filed: 1998-02-19
Abstract: The use of known NK-1 receptor antagonists of the formula 1, II or III according to US 3560510, US 4358446 and many others according to page 1a of the disclosure for the treatment of irritable bowel syndrome particularly abdominal pain.
Patent NZ-332072-A (NZ)
Title: The porcine heart fatty acid-binding protein encoding gene and methods to identify polymorphisms associated with body weight
Inventor: GERBENS FRANS
IPC: C12Q1/6809
Filed: 1997-03-27
Abstract: A novel sequence of the pig H-FABP gene, as well as methods of using said gene and its products are disclosed. Methods for detecting different alleles of the pig H-FABP gene, which different alleles are associated with differences in the genotypic and/or phenotypic traits of the pigs having those alleles are disclosed. Methods for distinguishing between alleles resulting in different phenotypes, particularly using techniques involving selective amplification of pig H-FABP gene derived materials are disclosed. These techniques are especially suitable for selecting animals to be used in breeding programs. Breeding programs employing such techniques are also disclosed.
Patent NZ-332917-A (NZ)
Title: Heterogeneous bimetallic palladium-gold catalyst for vinyl acetate production
Inventor: BROUSSARD JERRY A
IPC: C07C67/055
Filed: 1997-05-15
Abstract: A process for preparing a catalyst for the production of vinyl acetate from ethylene, acetic acid and oxygen is claimed comprising: a)	forming a precursor catalyst by impregnating a porous catalyst support medium with a solution of palladium compound and reducing the palladium compound to a first shell dispersion coating of colloidal palladium on the catalyst support surface and b)	impregnating the precursor catalyst with a solution of organometallic gold compound and reducing the gold compound to a second shell dispersion coating of colloidal gold on the catalyst support surface to form a bimetallic palladium-gold catalyst.
Patent NZ-334221-A (NZ)
Title: Polymers with at least one -SNO group per 1200 atomic mass units, and use for delivering nitric oxide in vivo
Inventor: STAMLER JONATHON S
IPC: A61K47/48
Filed: 1997-07-28
Abstract: Disclosed are polymers derivatized with at least one -SNOX group per 1200 atomic mass unit of the polymer. X is one or two. The polymer is an S-nitrosylated polysaccharide and is prepared by reacting a polythiolated polysaccharide with a nitrosylating agent under conditions suitable for nitrosylating free thiol groups. The polymers of the present invention can be used to coat medical devices to deliver nitric oxide in vivo to treatment sites.
Patent NZ-336128-A (NZ)
Title: Non-return device
Inventor: CURRID STEVE
IPC: E03C1/122
Filed: 1997-12-04
Abstract: non-return device (10) comprises a flat silicone rubber tubing (50) defining a pair of walls (70, 90) which separate to admit fluid in a forward direction but remain together to block fluid flow in a reverse direction.  A tubular body (30) surrounds the tubing (50) and comprises an off-set outlet (34) to provide an uninterrupted fluid flow surface for use in a non-vertical orientation.  The tubing (50) is mounted on a cartridge (130) which moves axially within the tubular body and compresses the tubing against the tubular body to effect a seal when the device is mounted on an outlet.  The tubing (50) provides good operational characteristics and sensitivity as a consequence of having a wall thickness which is 0.3 % to 3 % of its width.
Patent NZ-505553-A (NZ)
Title: 8-substituted alpha or beta L-guanosine analogs and uses thereof
Inventor: TAM ROBERT
IPC: C07H19/06
Filed: 1997-10-15
Abstract: A purine L-nucleoside has the formula 1 to 4.  A pharmaceutical composition thereof is useful for treating infections, infestations, neoplasm, or autoimmune diseases or for modulating Th1 and Th2 activities in a patient.